Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2004Clinical Pharmacology & Therapeutics

Systemic Exposure to Morphine and the Risk of Acute Chest Syndrome in Sickle Cell Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

EKErnest A. KopeckyTeva Pharmaceuticals (United States)SJSheila JacobsonWestern UniversityGideon KorenGideon KorenGeneral Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kopecky et al. (2004) studied this question.

synapsesocial.com/papers/6a8b20c1a42d46e0ffcab02ehttps://doi.org/10.1016/j.clpt.2003.10.007
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sickle Cell Chronic Lung Disease1988 · 285 citations
  2. 2Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death1994 · 3,376 citations
  3. 3Analgesia in Children with Sickle Cell Crisis: Comparison of Intermittent Opioids Vs. Continuous Intravenous Infusion of Morphine and Placebo-Controlled Study of Oxygen Inhalation1992 · 75 citations